Time course of changes in 6-sulfatoxymelatonin excretion in patients with breast cancer after various neoadjuvant chemotherapy options

The level of the metabolite 6-sulfatoxymelatonin (6-SOM) was studied on automedia before and after neoadjuvant systemic polyche- motherapy and neoadjuvant chemotherapy. Specific therapy was not found to result in normalization of 6-SOM levels, which may be regarded as a poor endogenous factor.

Bibliographic Details
Main Authors: Yu. S. Sidorenko, O. I. Kit, A. E. Lisutin, O. M. Semiletkin
Format: Article
Language:Russian
Published: ABV-press 2014-07-01
Series:Опухоли женской репродуктивной системы
Subjects:
Online Access:https://ojrs.abvpress.ru/ojrs/article/view/159